0000950170-24-137313.txt : 20241217 0000950170-24-137313.hdr.sgml : 20241217 20241217170003 ACCESSION NUMBER: 0000950170-24-137313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241216 FILED AS OF DATE: 20241217 DATE AS OF CHANGE: 20241217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nanavaty Maulik CENTRAL INDEX KEY: 0001529708 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40672 FILM NUMBER: 241556486 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001856725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: (408) 457-3700 MAIL ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 4 1 ownership.xml 4 X0508 4 2024-12-16 0001856725 Rani Therapeutics Holdings, Inc. RANI 0001529708 Nanavaty Maulik 2051 RINGWOOD AVE SAN JOSE CA 95131 true false false false false Stock Option (Right to Buy) 2.84 2024-12-16 4 D false 101276 D 2024-05-25 2033-05-24 Class A Common Stock 101276 0 D Stock Option (Right to Buy) 4.11 2024-12-16 4 A false 101276 A 2024-05-25 2033-05-24 Class A Common Stock 101276 101276 D Stock Option (Right to Buy) 2.84 2024-12-16 4 D false 15423 D 2031-07-28 Class A Common Stock 15423 0 D Stock Option (Right to Buy) 9.44 2024-12-16 4 A false 15423 A 2031-07-28 Class A Common Stock 15423 79317 D On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021. On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. Svai Sanford. Attorney-in-Fact for Maulik Nanavaty 2024-12-17